Can Diabetic Patients Undergo FDG PET-CT?

Introduction

18F-FDG PET-CT is an advanced imaging technique widely used in cardiac viability studies to assess the metabolic activity of heart muscle. Since this test relies on glucose metabolism, patients with diabetes often have concerns about whether they can safely undergo the scan. At Molecular Diagnostics and Therapy, we ensure proper protocols so diabetic patients can undergo FDG PET-CT safely and accurately.

Can Diabetic Patients Undergo the Scan?

Yes, diabetic patients can undergo FDG PET-CT, but proper preparation and blood sugar control are essential to obtain accurate results.

Why Blood Sugar Control is Important

The FDG tracer behaves like glucose in the body. If blood sugar levels are too high, normal glucose competes with the tracer, leading to poor image quality.

Ideal condition:

• Controlled blood glucose levels before the scan


• Stable metabolic state for accurate tracer uptake

Preparation Guidelines for Diabetic Patients

1. Monitor Blood Sugar Levels

• Blood glucose is checked before the scan


• The test may be rescheduled if levels are too high

2. Medication and Insulin Adjustment

• Doctors may modify insulin or oral medications


• Timing is carefully planned to avoid interference with the scan

3. Follow Dietary Instructions

• A low-carbohydrate, high-fat diet may be advised before the scan


• Avoid sugary foods and high-carb meals

4. Fasting Before the Scan

• Fasting for 6–8 hours is usually required


• Water is generally allowed

During the Scan

• Blood sugar is monitored


• The FDG tracer is injected


• Imaging is performed after proper uptake

What Happens if Blood Sugar is High?

• The scan may be delayed or rescheduled


• Additional preparation may be required


• This ensures accurate and reliable results

Benefits for Diabetic Patients

• Helps assess heart muscle viability


• Guides treatment decisions like angioplasty or bypass surgery


• Provides accurate diagnosis even in complex cardiac conditions

Safety Considerations

FDG PET-CT is safe and non-invasive for diabetic patients when done under medical supervision. Proper preparation minimizes risks and ensures effective imaging.

Conclusion

Diabetic patients can safely undergo FDG PET-CT with proper preparation and blood sugar control. Following medical guidance is key to achieving accurate results and effective diagnosis.

At Molecular Diagnostics and Therapy, we provide personalized care and clear instructions to ensure a smooth and safe scanning experience for every patient.